Literature DB >> 2563191

Sulphasalazine-induced lupus-like syndrome with cardiac tamponade in a patient with ulcerative colitis.

G Deboever, R Devogelaere, G Holvoet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2563191

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  9 in total

1.  Hypersensitivity reaction to balsalazide.

Authors:  V Adhiyaman; A Vaishnavi; S Froese
Journal:  BMJ       Date:  2000-03-04

2.  Drug points: Hypersensitivity reaction to balsalazide.

Authors:  V Adhiyaman; A Vaishnavi; S Froese
Journal:  BMJ       Date:  2001-09-01

3.  Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years.

Authors:  M M Gordon; D R Porter; H A Capell
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

4.  Sulphasalazine-induced systemic lupus erythematous in a patient with ankylosing spondylitis.

Authors:  W C Tsai; C J Chen; J H Yen; H W Liu
Journal:  Clin Rheumatol       Date:  2002-08       Impact factor: 2.980

5.  Pericardial tamponade in a patient with inactive ulcerative colitis.

Authors:  Ali Rezaie; Karen Wong; Gabor Gyenes
Journal:  Case Rep Med       Date:  2010-02-28

Review 6.  Pleuropericarditis related to the use of mesalamine.

Authors:  N Gujral; F Friedenberg; J Friedenberg; G Gabriel; M Kotler; G Levine
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

Review 7.  5-Aminosalicylic Acid-Associated Myocarditis and Pericarditis: A Narrative Review.

Authors:  Glen Brown
Journal:  Can J Hosp Pharm       Date:  2016-12-23

8.  Chronic pericarditis and pericardial tamponade associated with ulcerative colitis.

Authors:  Mitchell S Cappell; Albert Turkieh
Journal:  Dig Dis Sci       Date:  2008-01       Impact factor: 3.199

9.  Sulfasalazine-induced pericarditis in a patient with ulcerative colitis without recurrence when switching to mesalazine.

Authors:  Serge Perrot; Elisabeth Aslangul; Tali Szwebel; Houdha Gadhoum; Sophie Romnicianu; Claire Le Jeunne
Journal:  Int J Colorectal Dis       Date:  2007-04-18       Impact factor: 2.571
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.